论文部分内容阅读
目的:探讨2型糖尿病合并脑梗死的临床特点及治疗预后分析。方法:选择2012年8月~2013年8月期间在我院接受诊治的糖尿病合并脑梗死患者35例作为观察组。选择同期在我院接受诊治的糖尿病合并脑梗死患者38例作为对照组。对照组给予扩容、抗凝、降纤及活血化瘀等治疗;观察组在对照组基础上给予常规降糖治疗。2组患者均为21天为1个疗程观察患者神经功能缺损程度及治疗预后分析。2组患者在一般资料之间进行对比差异无显著性意义(P>0.05)。可进行对比分析。结果:2组患者在神经功能缺损程度(包括轻度缺损、中度缺损、重度缺损)差异之间对比有显著性差异(P<0.05);观察组治疗后总有效率(60.00%)显著低于对照组治疗后总有效率(89.47%),且有显著性差异(P<0.05)。结论:通过本文研究表明,2型糖尿病合并脑梗死患者治疗预后效果较差,且会致使神经功能发生严重损伤,值得临床注意。
Objective: To investigate the clinical features and prognosis of type 2 diabetes complicated with cerebral infarction. Methods: Thirty-five patients with diabetes mellitus and cerebral infarction treated in our hospital from August 2012 to August 2013 were selected as the observation group. Select the same period in our hospital for diagnosis and treatment of diabetic patients with cerebral infarction in 38 cases as a control group. The control group was treated with dilatation, anticoagulation, fibrinolysis and promoting blood circulation and removing blood stasis. The observation group was given routine hypoglycemic therapy on the basis of the control group. Two groups of patients were 21 days for a course of treatment observed in patients with neurological deficit and treatment prognosis analysis. There was no significant difference between the two groups in the general data (P> 0.05). Can be comparative analysis. Results: There was significant difference between the two groups in the difference of neurological deficit (including mild defect, moderate defect, severe defect) (P <0.05). The total effective rate (60.00%) in the observation group after treatment was significantly lower The total effective rate in the control group after treatment (89.47%), and there was a significant difference (P <0.05). Conclusion: This study shows that patients with type 2 diabetes mellitus and cerebral infarction have poor prognosis and may cause severe neurological damage, which is worthy of clinical attention.